Other ancillary, yet essential, cancer-driving genetic aberrations include loss of the genes CDKN2A, TP53, RB, or PTEN, or the genes encoding the PRC2 components SUZ12 or EED, and amplification of PDGFRA, EGFR, or MET (4, 5). Here, TP53 is linked to cancer.